Related Experiment Videos
Phenotyping cytochromes P450 with monoclonal antibodies
F K Friedman1, S S Park, T Fujino
1Laboratory of Molecular Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20205, USA.
Toxicologic Pathology
|January 1, 1984
Summary
Monoclonal antibodies (MAbs) are powerful tools for analyzing cytochrome P-450 content in tissues. These antibodies enable precise phenotyping and quantification of specific cytochrome P-450 isozymes, aiding in drug metabolism studies.
Area of Science:
- Biochemistry
- Pharmacology
- Immunology
Background:
- Cytochrome P-450 (CYP) isozymes are crucial for drug and carcinogen metabolism.
- Accurate phenotyping of CYP isozymes is essential for understanding individual metabolic differences.
- Existing methods for CYP analysis can be complex and time-consuming.
Purpose of the Study:
- To explore the utility of monoclonal antibodies (MAbs) for cytochrome P-450 (CYP) phenotyping.
- To demonstrate MAbs as tools for quantitative measurement of CYP isozymes.
- To highlight MAbs for rapid detection and purification of CYPs.
Main Methods:
- Development and application of MAbs targeting specific CYP isozymes.
- Utilizing MAbs to inhibit CYP-dependent reactions for quantitative analysis.
- Employing MAb-based radioimmunoassays for CYP detection.
- Using MAb-conjugated Sepharose for CYP immunopurification.
Main Results:
- MAbs successfully phenotyped both animal and human tissues for epitope-specific CYP content.
- MAb-based assays enabled quantitative measurement of specific CYP isozymes.
- Radioimmunoassays provided rapid, function-independent detection of CYPs.
- Immunopurification using MAbs offered a more efficient purification method.
Conclusions:
- MAbs provide a versatile and efficient approach to CYP analysis.
- MAbs enhance the study of CYP multiplicity and its role in drug metabolism.
- These antibodies offer new dimensions for investigating the relationship between CYP phenotype and metabolic outcomes.